|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 6.380 USD | -3.77% |
|
+7.59% | -77.89% |
| 08/10 | Capricor Therapeutics, Inc. - Special Call | |
| 05/10 | Capricor Therapeutics Presents Positive HOPE-3 Open-Label Extension Data On Deramiocel For Upper Limb Function In Duchenne Muscular Dystrophy | CI |
| Market Cap | 37Cr 33Cr 31Cr 28Cr 52Cr 3.52TCr 53Cr 364.4Cr 146.28Cr 1.85TCr 139.21Cr 136.25Cr 5.84TCr | P/E 2026 * |
-3.54x | P/E 2027 * | -4.36x |
|---|---|---|---|---|---|
| Enterprise Value | 37Cr 33Cr 31Cr 28Cr 52Cr 3.52TCr 53Cr 364.4Cr 146.28Cr 1.85TCr 139.21Cr 136.25Cr 5.84TCr | EV / Sales 2026 * |
6.66x | EV / Sales 2027 * | 6.56x |
| Free-Float |
90.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CAPR | Delayed | |
CBOE
| CAPR | Real-time | |
|
Boerse Muenchen
| 4LN2 | Real-time | |
|
Börse Stuttgart
| 4LN2 | Delayed | |
|
Tradegate
| 4LN2 | Real-time | |
|
Xetra
| 4LN2 | Delayed | |
|
Deutsche Boerse AG
| 4LN2 | Delayed |
Last Transcript: Capricor Therapeutics, Inc.
| 1 day | -3.77% | ||
| 1 week | +7.59% | ||
| Current month | -32.63% | ||
| 1 month | -32.63% | ||
| 3 months | +52.27% | ||
| 6 months | -81.00% | ||
| Current year | -77.89% |
| 1 week | 5.67 |  | 6.93 |
| 1 month | 5.67 | | 9.24 |
| Current year | 2.96 | | 36.82 |
| 1 year | 2.96 | | 40.37 |
| 3 years | 2.68 | | 40.37 |
| 5 years | 2.56 | | 40.37 |
| 10 years | 0.88 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 62 | 20/11/2013 |
Anthony Bergmann
DFI | Director of Finance/CFO | 40 | 01/01/2018 |
Michael Binks
CTO | Chief Tech/Sci/R&D Officer | - | 13/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Litvack
CHM | Chairman | 70 | 01/11/2013 |
David Musket
BRD | Director/Board Member | 68 | 20/11/2013 |
George Dunbar
BRD | Director/Board Member | 79 | 20/11/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/05/26 | Free | CHIEF COMMERCIAL OFFICER | 80,000 | 0.1383% | ||
| 18/05/26 | Exercice | Chief Financial Officer | 6,000 | 0.0104% | ||
| 13/05/26 | Exercice | Chairman | 7,874 | 0.0136% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.77% | +7.59% | +2.74% | +130.32% | 37Cr | |
| -0.62% | -1.87% | +46.31% | +56.99% | 6.38TCr | |
| +0.35% | +3.20% | +14.92% | +84.55% | 5.64TCr | |
| +0.53% | +1.96% | +15.37% | +106.81% | 5.46TCr | |
| -2.81% | -4.31% | +23.50% | +50.90% | 4.41TCr | |
| -0.33% | -1.93% | +20.15% | +98.45% | 4.21TCr | |
| +0.55% | +2.31% | +224.97% | +942.56% | 4.1TCr | |
| +3.27% | +47.96% | +112.67% | +96.48% | 3.49TCr | |
| +1.22% | -1.44% | +14.89% | +47.15% | 3.28TCr | |
| +0.89% | +20.55% | -42.03% | +373.03% | 2.47TCr | |
| Average | -0.07% | +7.54% | +43.35% | +198.72% | 3.95TCr | |
| Weighted average by Cap. | +0.17% | +5.45% | +48.46% | +186.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.57Cr 4.99Cr 4.59Cr 4.16Cr 7.77Cr 528.76Cr 7.92Cr 55Cr 22Cr 278.14Cr 21Cr 20Cr 877.16Cr | 5.65Cr 5.06Cr 4.66Cr 4.22Cr 7.89Cr 536.82Cr 8.04Cr 56Cr 22Cr 282.38Cr 21Cr 21Cr 890.54Cr |
| Net income | -13Cr -12Cr -11Cr -9.7Cr -18Cr -1.23TCr -18Cr -127.62Cr -51Cr -648.82Cr -49Cr -48Cr -2.05TCr | -8.8Cr -7.88Cr -7.25Cr -6.57Cr -12Cr -835.21Cr -13Cr -86Cr -35Cr -439.34Cr -33Cr -32Cr -1.39TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $6.380 | -3.77% | 33,57,108 |
| 29/26/29 | $6.630 | +6.42% | 33,30,890 |
| 28/26/28 | $6.230 | +2.13% | 29,82,549 |
| 27/26/27 | $6.100 | +6.27% | 34,75,565 |
| 26/26/26 | $5.740 | -3.20% | 15,52,916 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAPR Stock
Select your edition
All financial news and data tailored to specific country editions
